Related references
Note: Only part of the references are listed.Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis
Ahmed A. Abd-Rabou et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2020)
Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection
Kazumoto Murata et al.
HEPATOLOGY (2020)
Simulation of the Pharmacokinetics of Oseltamivir and Its Active Metabolite in Normal Populations and Patients with Hepatic Cirrhosis Using Physiologically Based Pharmacokinetic Modeling
Yong Chen et al.
AAPS PHARMSCITECH (2020)
Cyclodextrin solubilization and complexation of antiretroviral drug lopinavir: In silico prediction; Effects of derivatization, molar ratio and preparation method
Oluwatomide Adeoye et al.
CARBOHYDRATE POLYMERS (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines
Jie Yang et al.
DRUG METABOLISM REVIEWS (2020)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First -Pass Lymphatic Drug Sequestration and Long -Acting Pharmacokinetics of the Injectable Triple -HIV Drug Combination TLC -ART 101
Simone Perazzolo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Preclinical Pharmacokinetics of Lamivudine and Its Interaction with Schisandra chinensis Extract in Rats
Chi-Lin Li et al.
ACS OMEGA (2020)
Natural Oral Anticancer Medication in Small Ethanol Nanosomes Coated with a Natural Alkaline Polysaccharide
Jing Zhao et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms
Bodee Nutho et al.
BIOCHEMISTRY (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
Cornelis Smit et al.
CLINICAL PHARMACOKINETICS (2020)
Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
Dan Yan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Advances in cell-based permeability assays to screen drugs for intestinal absorption
Donna A. Volpe
EXPERT OPINION ON DRUG DISCOVERY (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease
Valeria Avataneo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes
Delaram Babadi et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19
Jahan S. Khalili et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives
Jiumeng Sun et al.
TRENDS IN MOLECULAR MEDICINE (2020)
The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection
Anna Halling Folkmar Andersen et al.
VIRUSES-BASEL (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
COVID-19, a pandemic or not?
[Anonymous]
LANCET INFECTIOUS DISEASES (2020)
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
Xi Wang et al.
CELL DISCOVERY (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Biomimetic Membrane-Structured Nanovesicles Carrying a Supramolecular Enzyme to Cure Lung Cancer
Jing Gu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Discovering small-molecule therapeutics against SARS-CoV-2
Vaibhav Tiwari et al.
DRUG DISCOVERY TODAY (2020)
The broad-spectrum antiviral recommendations for drug discovery against COVID-19
Abu Hazafa et al.
DRUG METABOLISM REVIEWS (2020)
An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia
Michael R. Charlton et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Development of anti-influenza agents from natural products
Zhi-Jun Zhang et al.
MEDICINAL RESEARCH REVIEWS (2020)
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Eugenia Quiros Roldan et al.
PHARMACOLOGICAL RESEARCH (2020)
Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee et al.
PHARMACOLOGICAL RESEARCH (2020)
COVID-19: A promising cure for the global panic
Balachandar Vellingiri et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Is hydroxychloroquine beneficial for COVID-19 patients?
Xing Li et al.
CELL DEATH & DISEASE (2020)
Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppression
Linda J. Visser et al.
PLOS PATHOGENS (2020)
Emerging role of nanosuspensions in drug delivery systems
Shery Jacob et al.
BIOMATERIALS RESEARCH (2020)
Biomimetic polysaccharide-cloaked lipidic nanovesicles/microassemblies for improving the enzymatic activity and prolonging the action time for hyperuricemia treatment
Lan Yang et al.
NANOSCALE (2020)
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
Hitoshi Yamamura et al.
CRITICAL CARE (2020)
Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis
Marie Lecronier et al.
CRITICAL CARE (2020)
The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir
Marlies Kubbinga et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Broad-spectrum coronavirus antiviral drug discovery
Allison L. Totura et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis
Qiuling Du et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
AZT acts as an anti-influenza nucleotide triphosphate targeting the catalytic site of A/PR/8/34/H1N1 RNA dependent RNA polymerase
Nataraj Sekhar Pagadala
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2019)
Antimalarial drugs and their metabolites are potent Zika virus inhibitors
Yingshan Han et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Lignan Dimers from Forsythia viridissima Roots and Their Antiviral Effects
Jungmoo Huh et al.
JOURNAL OF NATURAL PRODUCTS (2019)
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses
C. E. Hulseberg et al.
JOURNAL OF VIROLOGY (2019)
Bioadhesive Food Protein Nanoparticles as Pediatric Oral Drug Delivery System
Md Saiful Islam et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Predictive Value of Microdose Pharmacokinetics
Merel van Nuland et al.
CLINICAL PHARMACOKINETICS (2019)
Evaluation of improved oral bioavailability of ritonavir nanosuspension
Alptug Karakucuk et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Entecavir-loaded poly (lactic-co-glycolic acid) microspheres for long-term therapy of chronic hepatitis-B: Preparation and in vitro and in vivo evaluation
Chunyan Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Population Pharmacokinetics of Baloxavir Marboxil in Japanese Pediatric Influenza Patients
Hiroki Koshimichi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Cell line-dependent activation and antiviral activity of T-1105, the non-fluorinated analogue of T-705 (favipiravir)
Johanna Huchting et al.
ANTIVIRAL RESEARCH (2019)
Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus
Peng Zi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Synthesis and Biological Evaluation of NH2-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors
Yaping Hu et al.
MOLECULES (2019)
Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population
Nasir Ali Afsar et al.
SCIENTIFIC REPORTS (2019)
Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV-1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine
Nicole Bertoletti et al.
PROTEIN SCIENCE (2019)
Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management
Alessandra Zannella et al.
VIRUSES-BASEL (2019)
Functionalized selenium nanoparticles enhance the anti-EV71 activity of oseltamivir in human astrocytoma cell model
Jiayu Zhong et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery
Tejabhiram Yadavalli et al.
SCIENCE ADVANCES (2019)
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery
Alessandro Dalpiaz et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs
Kapilkumar Vithani et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Baicalein and baicalin as Zika virus inhibitors
Adrian Oo et al.
ARCHIVES OF VIROLOGY (2019)
Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs
Yuling Mao et al.
BIOMATERIALS (2019)
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
Karen A. Urtishak et al.
ONCOGENE (2019)
Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
Elena Morandi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
Martin Michaelis et al.
FRONTIERS IN MICROBIOLOGY (2019)
Versatile iron-catechol-based nanoscale coordination polymers with antiretroviral ligand functionalization and their use as efficient carriers in HIV/AIDS therapy
Ruben Solorzano et al.
BIOMATERIALS SCIENCE (2019)
Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections
David Lembo et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Adefovir dipivoxil loaded proliposomal powders with improved hepatoprotective activity: formulation, optimization, pharmacokinetic, and biodistribution studies
Ghada A. Abdelbary et al.
JOURNAL OF LIPOSOME RESEARCH (2018)
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
Katherine L. Seley-Radtke et al.
ANTIVIRAL RESEARCH (2018)
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates
Alessandro Giuliani et al.
DRUG DELIVERY (2018)
Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood-brain barrier into brain
Lopamudra Dutta et al.
DRUG DELIVERY (2018)
Improved delivery of natural alkaloids into lung cancer through woody oil-based emulsive nanosystems
Jing Zhao et al.
DRUG DELIVERY (2018)
Cyclodextrins as excipients in tablet formulations
Jaime Conceicao et al.
DRUG DISCOVERY TODAY (2018)
Peramivir conjugates as orally available agents against influenza H275Y mutant
Peng-Cheng Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Injectable PLGA Adefovir microspheres; the way for long term therapy of chronic hepatitis-B
Margrit M. Ayoub et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Semisolid self-microemulsifying drug delivery systems (SMEDDSs): Effects on pharmacokinetics of acyclovir in rats
Ljiljana Djekic et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Encapsulation of zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug delivery
K. S. Joshy et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain
Bhavin K Patel et al.
International Journal of Nanomedicine (2018)
Microsuspension of fatty acid esters of entecavir for parenteral sustained delivery
Myoung Jin Ho et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection
Romina Quercia et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2018)
Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium
Carmen Mirabelli et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation
John C. Kraft et al.
JOURNAL OF CONTROLLED RELEASE (2018)
The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Soluplus micelles for acyclovir ocular delivery: Formulation and cornea and sclera permeability
Angela Varela-Garcia et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Liquorice (Glycyrrhiza glabra ): A phytochemical and pharmacological review
Giulia Pastorino et al.
PHYTOTHERAPY RESEARCH (2018)
Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications
Eknath Ahire et al.
ACTA PHARMACEUTICA SINICA B (2018)
In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit
Takeshi Noshi et al.
ANTIVIRAL RESEARCH (2018)
Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function
Yejin Jang et al.
JOURNAL OF VIROLOGY (2018)
HPLC-MS/MS analysis of peramivir in rat plasma: Elimination of matrix effect using the phospholipid-removal solid-phase extraction method
Mingdao Lei et al.
BIOMEDICAL CHROMATOGRAPHY (2018)
The delivery of arbidol by salt engineering: synthesis, physicochemical properties and pharmacokinetics
Xiaoting Li et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
Letermovir for the management of cytomegalovirus infection
Lyndsey J. Bowman et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions
Pradip W. Dhore et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2017)
Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1
Rocio M. Neri-Bazan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir
Betty Gourdon et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies
Utthara Nayar et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate
Jin Soo Shin et al.
JOURNAL OF MICROBIOLOGY (2017)
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
Hanadi Sinokrot et al.
MOLECULES (2017)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment
Dirk Kropeit et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret)
Yutao Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Drug Metabolism in the Liver
Omar Abdulhameed Almazroo et al.
CLINICS IN LIVER DISEASE (2017)
Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
Lisa Oestereich et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3
Caterina Frezza et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein
Xia Liu et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Chitosan-modified lipid nanovesicles for efficient systemic delivery of L-asparaginase
Shengli Wan et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles
Garima Joshi et al.
DRUG DELIVERY (2016)
Reduction Sensitive Lipid Conjugates of Tenofovir: Synthesis, Stability, and Antiviral Activity
Kyle E. Giesler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin
Navid Goodarzi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue
Tuba Incecayir et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
Eve-Isabelle Pecheur et al.
JOURNAL OF VIROLOGY (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models
Rodrigo Delvecchio et al.
VIRUSES-BASEL (2016)
Mutagenic Effects of Ribavirin on Hepatitis E VirusViral Extinction versus Selection of Fitness-Enhancing Mutations
Daniel Todt et al.
VIRUSES-BASEL (2016)
An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults
Hye Won Lee et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Ribavirin is effective against drug-resistant H7N9 influenza virus infections
Yuhai Bi et al.
PROTEIN & CELL (2016)
Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changes
Yunli Zhou et al.
SCIENTIFIC REPORTS (2016)
Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever
Brian B. Gowen et al.
ANTIVIRAL RESEARCH (2015)
Metabolic mapping of A3 adenosine receptor agonist MRS5980
Zhong-Ze Fang et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection
T. H. Senanayake et al.
MOLECULAR PHARMACEUTICS (2015)
Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats
Prashant Kumar et al.
PLOS ONE (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo
Ruediger Kaspera et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Modified pullulan nanoparticles for oral delivery of lopinavir: Formulation and pharmacokinetic evaluation
Punna Rao Ravi et al.
CARBOHYDRATE POLYMERS (2014)
Solid self-microemulsifying drug delivery system of ritonavir
Ashish Deshmukh et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2014)
A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation
Punna Rao Ravi et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Azithromycin Cationic Non-Lecithoid Nano/Microparticles Improve Bioavailability and Targeting Efficiency
Meng Zhong et al.
PHARMACEUTICAL RESEARCH (2014)
Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
Lisa Oestereich et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Fundamental aspects of solid dispersion technology for poorly soluble drugs
Yanbin Huang et al.
ACTA PHARMACEUTICA SINICA B (2014)
Pharmacokinetics, Metabolism, and Excretion of the Antiviral Drug Arbidol in Humans
Pan Deng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies
Shamsunder Dodiya et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2013)
Exploring dried blood spot sampling technique for simultaneous quantification of antiretrovirals: lamivudine, stavudine and nevirapine in a rodent pharmacokinetic study
Ramakrishna Nirogi et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
Oxidation of the Antiviral Drug Acyclovir and Its Biodegradation Product Carboxy-acyclovir with Ozone: Kinetics and Identification of Oxidation Products
Carsten Prasse et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2012)
Intestinal permeability of lamivudine (3TC) and two novel 3TC prodrugs. Experimental and theoretical analyses
Maria S. Gualdesi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
PharmGKB summary: zidovudine pathway
Yogita Ghodke et al.
PHARMACOGENETICS AND GENOMICS (2012)
Gelucire44/14 as a Novel Absorption Enhancer for Drugs with Different Hydrophilicities: in Vitro and in Vivo Improvement on Transcorneal Permeation
Rui Liu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir
R. A. B. van Waterschoot et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza Pharmacokinetic and Pharmacodynamic Characteristics
Nicolas Widmer et al.
CLINICAL PHARMACOKINETICS (2010)
A Novel Anti-HIV Dextrin-Zidovudine Conjugate Improving the Pharmacokinetics of Zidovudine in Rats
Sumalee Wannachaiyasit et al.
AAPS PHARMSCITECH (2008)
Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2′-C-methylcytidine, the active component of valopicitabine
Lotte Coelmont et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity
GA Levy et al.
HEPATOLOGY (2006)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Effective metabolism and long intracellular half life of the anti-Hepatitis B agent adefovir in hepatic cells
AS Ray et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Pharmacokinetics and metabolism of [14C]ribavirin in rats and cynomolgus monkeys
CC Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds
BJ Aungst et al.
PHARMACEUTICAL RESEARCH (2000)
Share Paper
